当前位置： SCI文献检索 > THROMBOSIS RESEARCH期刊下所有文献 > Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease.

Influence of endothelial nitric oxide synthase gene polymorphisms (-786T>C, 4a4b, 894G>T) in Korean patients with coronary artery disease.

Abstract：

INTRODUCTION:Endothelium-derived nitric oxide (NO) is synthesized from l-arginine by endothelial nitric oxide synthase (eNOS) encoded by the eNOS3 gene on chromosome 7. The effects of the eNOS polymorphisms with the risk of coronary artery disease are conflicting. In this study, we investigated the association of the eNOS genotypes with coronary artery disease in Koreans. MATERIALS AND METHODS:A case-control study was performed to evaluate the association between the eNOS -786T>C, 4a4b, or 894G>T polymorphism and coronary artery disease. 147 consecutive patients with coronary artery disease and 222 healthy controls were recruited. The genotypes of eNOS -786T>C and 894G>T polymorphisms were determined by the polymerase chain reaction-restriction fragment length polymorphism analysis. The genotypes of a 27 bp insertion/deletion in intron 4 (eNOS 4a4b) were determined by the banding pattern on gel electrophoresis. RESULTS:The eNOS -786T>C (odds ratio [OR]; 1.61, 95% confidence interval [CI]; 0.97-2.69), 894G>T (OR; 1.12, 95% CI; 0.65-1.92) and 4a4b (OR; 1.44, 95% CI; 0.87-2.39) polymorphisms were not an independent predisposition factor to coronary artery disease. However, a subgroup analysis adjusted with various cardiovascular risk factors confirmed positive association of the -786T>C polymorphism in CAD patients with hypertension and a smoking history and also a significant association of the intron 4 genotypes with a smoking history, but no significance has been found in the eNOS polymorphisms of 894G>T upon any risk adjustment. In this study we also found that the distribution of heterozygotes (-786TC, 894GT, and 4a4b) and variant homozygotes for the -786C, 894T, and intron 4a alleles of eNOS in Koreans were significantly lower than in Caucasian populations. CONCLUSIONS:The present study demonstrates that polymorphisms of the eNOS -786T>C and 4a4b are associated with coronary artery disease with adjustments for cardiovascular risk factors in the Koreans.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Kim IJ,Bae J,Lim SW,Cha DH,Cho HJ,Kim S,Yang DH,Hwang SG,Oh D,Kim NK

doi

10.1016/j.thromres.2006.06.005

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

579-85

issue

5

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(06)00201-5

journal_volume

119

pub_type

杂志文章

相关文献

THROMBOSIS RESEARCH文献大全
  • Exploring soluble urokinase plasminogen activator receptor and its relationship with arterial stiffness in a bi-ethnic population: the SAfrEIC-study.

    abstract：INTRODUCTION:Elevated soluble urokinase-type plasminogen activator receptor (suPAR) indicates an inflammatory state caused by conditions such as HIV and cancer. Recently suPAR was identified as an indicator of cardiovascular disease (CVD). CVD is highly prevalent in black South Africans, but the potential role of suPAR...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2011.10.034

    authors： Schutte AE,Myburgh A,Olsen MH,Eugen-Olsen J,Schutte R

    更新日期：2012-08-01 00:00:00

  • Platelet membrane glycoprotein V: characterization of the thrombin-sensitive glycoprotein from human platelets.

    abstract：:Human platelets contain a single membrane glycoprotein which is susceptible to thrombin proteolysis, glycoprotein V. We have purified 1 mg of glycoprotein V from 10(13) platelets using a combination of gel filtration, hydroxylapatite and ion-exchange chromatographies. Glycoprotein V has a blocked amino-terminus. Follo...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(89)90113-8

    authors： Zafar RS,Walz DA

    更新日期：1989-01-01 00:00:00

  • Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testing.

    abstract：INTRODUCTION:To determine whether the HIT IgG class platelet factor 4 (PF4) enzyme immunoabsorbant assay (EIA) influenced the duration of parenteral direct thrombin inhibitor (pDTI) therapy or bleeding risk in patients started on pDTI for a presumed diagnosis of HIT. MATERIALS/METHODS:187 patients started on pDTI for ...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2014.04.030

    authors： Reagan JL,Ingham RR 2nd,Dalia S,Butera JN,Sweeney JD

    更新日期：2014-07-01 00:00:00

  • Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population.

    abstract：INTRODUCTION:Plasma viscosity (PV) constitutes an independent important predictor of initial and recurrent cardiac events and mortality. It has been suggested that there is a geographical variation in PV values related to coronary event rates. Little information exists regarding PV in Spain. Therefore, our objective wa...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2006.11.009

    authors： Vayá A,Simó M,Santaolaria M,Carrasco P,Corella D

    更新日期：2007-01-01 00:00:00

  • Protective activity of defibrotide against lethal acute myocardial ischemia in the cat.

    abstract：:Defibrotide (D) is a natural polydeoxyribonucleotide from mammalian lungs with profibrinolytic and antithrombotic activities. D also has PGI2-stimulating and tissue plasminogen activator (TPA)-releasing activities, but has no anticoagulant properties. The protective effects of D were demonstrated very recently in a mo...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(86)90265-3

    authors： Niada R,Porta R,Pescador R,Mantovani M,Prino G

    更新日期：1986-05-01 00:00:00

  • Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.

    abstract：BACKGROUND:The level of platelet reactivity (PR) inhibition obtained after P2Y12-ADP receptor antagonist loading dose (LD) is associated with the ischemic and bleeding risk following percutaneous coronary intervention (PCI) in acute coronary syndromes (ACS). OBJECTIVE:We aimed to evaluate the level of PR inhibition ac...

    journal_title：Thrombosis research

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.thromres.2013.04.030

    authors： Laine M,Toesca R,Berbis J,Frere C,Barnay P,Pansieri M,Peyre JP,Michelet P,Bessereau J,Camilleri E,Helaf O,Camaleonte M,Paganelli F,Dignat-George F,Bonello L

    更新日期：2013-07-01 00:00:00

  • Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplasty.

    abstract：:We have investigated fibrinolytic parameters in 33 patients with peripheral arterial occlusive disease (PAOD) before and 6, 24, and 48 hours after percutaneous transluminal angioplasty (PTA) as well as in 35 gender-matched healthy controls, whose mean age was not significantly different from the mean age of the patien...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/s0049-3848(99)00002-x

    authors： Roller RE,Janisch S,Carroll V,Kvas E,Pilger E,Binder BR,Wojta J

    更新日期：1999-05-15 00:00:00

  • Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management.

    abstract：:Patients with the nephrotic syndrome are at increased risk of developing venous and arterial thromboembolism, the most common of which is renal vein thrombosis. There are several unanswered or controversial issues relating to the nephrotic syndrome and thromboembolism, which include the mechanism of thromboembolism, a...

    journal_title：Thrombosis research

    pub_type： 杂志文章,评审

    doi：10.1016/j.thromres.2005.03.030

    authors： Singhal R,Brimble KS

    更新日期：2006-01-01 00:00:00

  • Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.

    abstract：:To explore social aspects of asymptomatic carriership of factor V Leiden mutation (FVL) and how carriers have experienced procedure of screening for FVL, we have performed a qualitative study using semi-structured interviews. Seventeen carriers of FVL without history of venous thromboembolism (VTE) were interviewed. C...

    journal_title：Thrombosis research

    pub_type： 临床试验,杂志文章

    doi：10.1016/j.thromres.2004.02.002

    authors： Bank I,Scavenius MP,Büller HR,Middeldorp S

    更新日期：2004-01-01 00:00:00

  • Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.

    abstract：BACKGROUND:Early aspirin treatment is widely used to inhibit platelet activity and to reduce morbidity and mortality in patients presenting with an acute myocardial infarction or a stroke. A number of different aspirin formulations have been used for this purpose; however, a comparison of their effectiveness in inhibit...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2005.10.001

    authors： Schwertner HA,McGlasson D,Christopher M,Bush AC

    更新日期：2006-01-01 00:00:00

  • Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women.

    abstract：INTRODUCTION:Normal pregnancy is associated with hypercoagulable state. Elevated markers of coagulation and fibrinolytic system activation indicate increased thrombin activity and increased fibrinolysis following fibrin formation throughout pregnancy. These changes exceed the biological variability in most cases. Haemo...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2013.02.005

    authors： Réger B,Péterfalvi A,Litter I,Pótó L,Mózes R,Tóth O,Kovács GL,Losonczy H

    更新日期：2013-04-01 00:00:00

  • A sensitive competitive binding assay for exogenous and endogenous heparins.

    abstract：:A new type of assay for heparins has been devised, in which the test material competes with 125I-labelled heparin for binding to protamine-Sepharose. The assay is very sensitive and will measure heparin concentrations down to 10 ng ml-1. It responds to both the degree of sulphation and the molecular weight of acidic p...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(82)90056-1

    authors： Dawes J,Pepper DS

    更新日期：1982-08-15 00:00:00

  • Protein S activity in patients with heredofamilial protein S deficiency and in patients with juvenile venous thrombosis. Results of a functional method.

    abstract：:Using an ACL 300R coagulometer (Instrumentation Laboratory) we assessed the clinical usefulness of a new method to measure PS activity (PS:Act), based on the prolongation of prothrombin time of a mixture of diluted plasma sample, PS depleted plasma previously incubated with Protac for protein C activation, bovine thro...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(91)90065-5

    authors： Maccaferri M,Legnani C,Preda L,Palareti G

    更新日期：1991-12-15 00:00:00

  • Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets.

    abstract：:The inhibitory effects of several antiinflammatory agents on the specific binding of tritiated 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphorylcholine, (platelet activating factor, PAF), with its receptor on isolated rabbit platelet plasma membranes were investigated. Several potent cyclooxygenase inhibitors do not inhibi...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(84)90256-1

    authors： Hwang SB,Cheah MJ,Lee CS,Shen TY

    更新日期：1984-06-15 00:00:00

  • Combination and comparison of two models in prognosis of pulmonary embolism: results from TUrkey Pulmonary Embolism Group (TUPEG) study.

    abstract：BACKGROUND:Clinical parameters, biomarkers and imaging-based risk stratification are widely accepted in pulmonary embolism(PE). The present study has investigated the prognostic role of simplified Pulmonary Embolism Severity Index (sPESI) score and the European Society of Cardiology (ESC) model. METHODS:This prospecti...

    journal_title：Thrombosis research

    pub_type： 杂志文章,多中心研究

    doi：10.1016/j.thromres.2014.02.032

    authors： Ozsu S,Ozlu T,Sentürk A,Uçar EY,Kırkıl G,Kadıoğlu EE,Altınsoy B,Saylan B,Selimoğlu HŞ,Dabak G,Tutar N,Uysal A,TUPEG Study Investigators.

    更新日期：2014-06-01 00:00:00

  • Central thromboembolism is a possible predictor of right heart dysfunction in normotensive patients with acute pulmonary embolism.

    abstract：BACKGROUND:Right heart dysfunction is a crucial factor in risk stratification of normotensive patients with pulmonary embolism. Apart from biomarkers, determinants of right heart dysfunction in this group of patients are not yet well established. AIM AND METHOD:In order to identify such determinants, we analysed data ...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2010.06.009

    authors： Berghaus TM,Haeckel T,Behr W,Wehler M,von Scheidt W,Schwaiblmair M

    更新日期：2010-09-01 00:00:00

  • Construction and its expression of a new retroviral vector containing a human blood coagulation factor IX cDNA.

    abstract：:We constructed a new factor IX expression vector containing a full length factor IX cDNA. The Moloney Murine Leukemia Virus (MoMLV)-based retroviral vector pLRNL was cloned with the entire coding region of human factor IX down stream of the promoter of Rous sarcoma virus, giving rise to the construct pL9RNL. The GP+E ...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(93)90038-p

    authors： Matsushita T,Emi N,Takahashi I,Takamatsu J,Saito H

    更新日期：1993-02-15 00:00:00

  • The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.

    abstract：OBJECTIVE:To investigate the mechanism underlying the hypercoagulable state in severe pre-eclampsia. METHODS:Plasma tissue factor (TF) and tissue factor pathway inhibitor (TFPI) expression from pre-eclampsia patients and healthy pregnant controls were determined by ELISA. Placental TF and TFPI gene and protein express...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2010.02.012

    authors： Teng Y,Jiang R,Lin Q,Ding C,Ye Z

    更新日期：2010-07-01 00:00:00

  • Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.

    abstract：:Four calcium channel blockers (nimodipine, nifedipine, verapamil and diltiazem) of three chemical classes were tested in vitro for inhibition of platelet aggregation using heparinized human platelet rich plasma. Both ADP- and thrombin-induced aggregation were inhibited as was the biosynthesis of thromboxane A2 in resp...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(84)90241-x

    authors： Onoda JM,Sloane BF,Honn KV

    更新日期：1984-06-01 00:00:00

  • Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin.

    abstract：:Resveratrol (3, 4', 5-trihydroxystilbene), a natural polyphenol, is found in some plants that are used in human nutrition. Grapes are a major source for resveratrol, and a significant amount can also be found in red wine. Several experimental studies have demonstrated biological properties of resveratrol, especially i...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/s0049-3848(02)00273-6

    authors： Olas B,Wachowicz B,Saluk-Juszczak J,Zieliński T

    更新日期：2002-08-15 00:00:00

  • Erik von Willebrand.

    abstract：:In 1926, Erik von Willebrand, a Finnish physician, published the first manuscript describing a haemorrhagic disorder in people who were living on the Aland islands off the coast of Finland. This disorder is now known by the name of its discoverer. Since this early observation, von Willebrand disease has been extensive...

    journal_title：Thrombosis research

    pub_type： 传,历史文章,杂志文章

    doi：10.1016/j.thromres.2007.03.010

    authors： Berntorp E

    更新日期：2007-01-01 00:00:00

  • Morphology of the interaction of collagen fibrils with normal human platelets and thrombasthenic platelets.

    abstract：:The ultrastructure of the platelet contacts with collagen fibrils (CF) as well as the course taken by CF on the platelet surface were studied on ultrathin sections of platelets and CF. Platelets from normal donors and from a patient with thrombasthenia were incubated in citrated plasma with collagen. For electron micr...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(86)90326-9

    authors： Ruf A,Morgenstern E,Janzarik H,Lüscher EF

    更新日期：1986-11-15 00:00:00

  • Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.

    abstract：INTRODUCTION:Atherosclerosis, the underlying disorder of coronary artery disease (CAD), is an inflammatory process involving multiple molecular pathways. Chemokine-mediated mechanisms are potent regulators of atherosclerosis. Genetic variations that alter such signaling pathways could affect susceptibility to CAD. We i...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2005.12.016

    authors： Apostolakis S,Baritaki S,Kochiadakis GE,Igoumenidis NE,Panutsopulos D,Spandidos DA

    更新日期：2007-01-01 00:00:00

  • Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density.

    abstract：INTRODUCTION:In contrast to unfractionated heparin (UFH), use of low-molecular weight heparin (LMWH) during pregnancy has not been reported to be associated with a significant decrease in bone mineral density (BMD). The aim of this study was to investigate whether long-term use of LMWH during pregnancy is associated wi...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/j.thromres.2016.05.016

    authors： Galambosi P,Hiilesmaa V,Ulander VM,Laitinen L,Tiitinen A,Kaaja R

    更新日期：2016-07-01 00:00:00

  • PO-62 - Remote ischemic preconditioning in head and neck cancer reconstruction - a randomized controlled trial.

    abstract：INTRODUCTION:In reconstructive head and neck cancer surgery, tissue flaps are transferred to the surgical defect and revascularized by anastomosis of small vessels. Cancer patients are in a hypercoagulable state with high risk of peri- and postoperative thrombotic events. Thrombosis to the tissue flap anastomoses or mi...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/S0049-3848(16)30195-5

    authors： Krag AE,Kiil BJ,Hvas CL,Eschen GT,Hvas AM

    更新日期：2016-04-01 00:00:00

  • Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: an analysis of the CERTIFY study.

    abstract：INTRODUCTION:There is an exponential rise of thromboembolic risk with age because of co-morbidities, immobility and pharmacotherapy. We aimed to investigate the benefits and risks of heparin prophylaxis in very elderly patients ≥80 years and the type of heparin used in a subgroup analysis of the CERTIFY trial. PATIENT...

    journal_title：Thrombosis research

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.thromres.2011.05.002

    authors： Schellong SM,Gerlach HE,Tebbe U,Haas S,Melzer N,Abletshauser C,Sieder C,Bramlage P,Riess H,Bauersachs R

    更新日期：2011-11-01 00:00:00

  • Human pharmacological studies of a defined low molecular weight heparin fraction (Fragmin) evidence for a simultaneous inhibition of factor Xa and IIa (thrombin).

    abstract：:The effect of a low molecular weight heparin (Fragmin) (20-80 U/kg) was studied in 10 healthy male volunteers after intravenous administration. Clotting abnormalities are extensive shortly after injection, lasting for 1-2 hours depending on heparin dosage. Dilute thrombin time, showing a close correlation to anti-F-Xa...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/0049-3848(88)90257-5

    authors： Andrassy K,Mörike K,Koderisch J,Weber E

    更新日期：1988-03-15 00:00:00

  • The Factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation.

    abstract：:In the present study a new clotting assay for the detection of an increased resistance of coagulation factor V against degradation by activated protein C (Factor V Leiden mutation, FVLM) was evaluated. The Factor V (Leiden) Test (Gradipore, North Ryde NSW, Australia) is based on the dilute Russell Viper Venom Time (DR...

    journal_title：Thrombosis research

    pub_type： 杂志文章

    doi：10.1016/s0049-3848(99)00090-0

    authors： Quehenberger P,Handler S,Mannhalter C,Kyrle PA,Speiser W

    更新日期：1999-10-15 00:00:00

  • Platelet activation and antiplatelet therapy in sepsis: A narrative review.

    abstract：:Platelet activation plays an important role in the development of sepsis. During sepsis, platelet activation leads to endothelial cell injury and promotes neutrophil extracellular trap and microthrombus formation, exacerbating septic coagulation and inflammatory reactions. The resultant induction or aggravation of dis...

    journal_title：Thrombosis research

    pub_type： 杂志文章,评审

    doi：10.1016/j.thromres.2018.04.007

    authors： Wang Y,Ouyang Y,Liu B,Ma X,Ding R

    更新日期：2018-06-01 00:00:00

  • Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy: correlations with PAI-1 and t-PA plasma levels.

    abstract：BACKGROUND:In the rat liver, growth hormone (GH) affects the synthesis of vitamin-K-dependent factors, including Protein C (prot.C) and protein S (prot.S), two natural anticoagulants that prevent hypercoagulable states. Adults with GH deficiency (GHD) are at risk of thrombotic events. High circulating levels of PAI-1 a...

    journal_title：Thrombosis research

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1016/j.thromres.2010.08.028

    authors： Di Minno MN,Pezzullo S,Palmieri V,Di Somma C,Lupoli R,Valle D,Lombardi G,Di Minno G

    更新日期：2010-12-01 00:00:00